The foundations for a new standard of care
We are building upon the INVU™ platform with our newest FDA clearance* for noninvasive uterine activity monitoring. With more comprehensive fetal surveillance we are unlocking the ability to perform remote non-stress tests and further advancing the shift from passive pregnancy monitoring to proactive management.
Data captured from INVU™ sessions and other robust pregnancy data sets are being combined to develop AI based models that will enable comprehensive data analysis and predictive pathways, helping identify trends that will change the way pregnancy is managed and ultimately lead to better outcomes for moms and babies.
Join our movement